跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
HL-50
首页
药物
HL-50
HL-50
未知生产厂商
订阅
生成 AI 研报
Share to Twitter
Share to Facebook
Share to LinkedIn
Share to Reddit
摘要
临床试验
审批记录
专利
每项发明一条,涵盖美国、欧洲、PCT 与中国的同族专利。
Anti-leukemia medicine
CN 1377644 A
申请人: UNIV ZHONGNAN
优先权: 2001
CN
Application of toosendanin as anti-tumor medicine
CN 1476829 A
申请人: SHANGHAI INSTITUTES FOR BIOLOGICAL SCIENCES
优先权: 2003
CN
Use of chitosan in powder form as antifungal agent in the treatment of food liquids of vegetable origin prepared by fermentation
EP 2727945 A1
申请人: KITOZYME S A
优先权: 2010
EP
Fly maggot extractive as well as preparation method and application thereof
CN 101991608 B
申请人: ZHEJIANG ACADEMY MEDICAL SCI
优先权: 2010
CN
香豆素木脂体类化合物的制备方法及其抗海洋污损方面的应用
CN 102659802 B
申请人: 江苏省中国科学院植物研究所
优先权: 2012
CN
Method for synthesizing 4-methyl salicylacylhydrazone copper complex with antitumor activity
CN 103896969 A
申请人: UNIV HENAN POLYTECHNIC
优先权: 2014
CN
Traditional Chinese medicine for treating leukemia and application thereof
CN 106177611 A
申请人: TIANJIN SCIPHARMACN LTD
优先权: 2015
CN
Method for treating leukemia cell strains through zedoary turmeric oil
CN 106540175 A
申请人: BAI JIANXUE
优先权: 2015
CN
Aquatic protein active peptide preparing method without adopting high-temperature treatment
CN 105603031 A
申请人: UNIV GUANGDONG OCEAN
优先权: 2016
CN
A method of preparing crotonoside and antitumor applications of the crotonoside
CN 106046090 A
申请人: NANJING ZELANG MEDICAL TECH CO
优先权: 2016
CN
第 1 / 2 页
上一页
下一页
药物
反馈